Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Coherus Biosciences (CHRS)
NASDAQ:CHRS
Holding CHRS?
Track your performance easily
See the Price Targets and Ratings of:
CHRS Analyst Ratings
Moderate Buy
5 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CHRS Stock 12 Month Forecast
Average Price Target
$7.13
▲(539.46% Upside)
| Highest Price Target$12.00 | Average Price Target$7.13 | Lowest Price Target$1.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
09/16/24
Truist Financial
Assigned
09/16/24
Robert W. Baird
Reiterated
09/16/24
Barclays
Reiterated
08/19/24
TD Cowen
Reiterated
08/09/24
J.P. Morgan
Reiterated
07/15/24
JonesTrading
―
Buy
―
Reiterated
05/30/24
TD Cowen reiterates Buy Rating on Coherus Biosciences (CHRS)TD Cowen analyst Michael Nedelcovych, Ph.D. reiterated a Buy rating on Coherus Biosciences (NASDAQ: CHRS).
Maxim Group
―
Hold
―
Reiterated
05/17/24
Coherus Biosciences (CHRS) Gets a Hold from Maxim Group
Citi
$11
Buy
886.55%
Upside
Reiterated
03/14/24
Analysts Offer Insights on Healthcare Companies: Coherus Biosciences (NASDAQ: CHRS) and Solid Biosciences (NASDAQ: SLDB)
Best Analysts Covering Coherus Biosciences
Which Analyst Should I Follow If I Want to Buy CHRS and Sell After:
1 Month
xxx
Success Rate
10/23 ratings generated profit
Average Return
-3.18%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 43.48% of your transactions generating a profit, with an average return of -3.18% per trade.
3 Months
xxx
Success Rate
6/23 ratings generated profit
Average Return
-11.83%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 26.09% of your transactions generating a profit, with an average return of -11.83% per trade.
1 Year
Success Rate
2/23 ratings generated profit
Average Return
-38.61%
reiterated a buy rating last month
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 8.70% of your transactions generating a profit, with an average return of -38.61% per trade.
2 Years
xxx
Success Rate
0/23 ratings generated profit
Average Return
-54.33%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -54.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CHRS Analyst Recommendation Trends
Rating
Apr 24
May 24
Jul 24
Aug 24
Sep 24
Strong Buy
13
10
8
11
8
Buy
2
5
3
4
2
Hold
0
1
2
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
16
13
18
12
Each month's total comprises the sum of three months' worth of ratings.
CHRS Financial Forecast
CHRS Stock Forecast FAQ
What is CHRS’s average 12-month price target, according to analysts?
Based on analyst ratings, Coherus Biosciences’s 12-month average price target is $7.13.
What is CHRS’s upside potential, based on the analysts’ average price target?
Coherus Biosciences has 539.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CHRS a Buy, Sell or Hold?
Coherus Biosciences has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.
What is Coherus Biosciences’s price target?
The average price target for Coherus Biosciences is $7.13. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $1.50. The average price target represents 539.46% Increase from the current price of $1.115.
The highest analyst price target is $12.00 ,the lowest forecast is $1.50. The average price target represents 539.46% Increase from the current price of $1.115.
What do analysts say about Coherus Biosciences?
Coherus Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of CHRS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.